SenesTech, Inc.functions as a biotech platform and research company developing and commercializing a proprietary technology for managing animal pest populations through fertility control. Whether canines, possums, rodents, or any number of other species, unregulated animal populations can create a diverse range of pressing problems across the globe. In India, for example, 60,000 children die from rabies annually, a disease transmitted by infected dogs. New Zealand's primary economic driver, the livestock industry, is threatened by the brush tail possum, vector of bovine tuberculosis. Even within the United States, uncontrolled rat populations cause destruction in urban, agricultural and industrial sectors; SenesTechs first product had focused on proliferation of rats in both urban and agricultural settings. Readily consumed by rats, the product leaves them permanently non-reproductive with no other observable side effects: a new paradigm to the science of pest control. The firms is gearing up for the process of EPA registration, after which it will be available for commercial sale. Meanwhile, tests ranging from the New York Subway, the neighborhoods of Metropolitan Boston, and the rice fields in Southeast Asia have yielded promising results. With EPA registration completed, path to commercialization involved strategic partnerships with major manufacturer, and a leading pest control service provider actively seeking an alternative to traditional pest management methods. Early promise also offered humane control of other pest species from deer to wild pigs. Long-term, there is also potential for a SenesTech formulation to become a non-surgical solution for the spaying and neutering of feral cats and dogs.
